Tousignant Jennifer sold VRDN
December 31, 2025 · Form 4 insider transaction
Tousignant Jennifer sold 2,272 shares of Viridian Therapeutics, Inc. at $31.16 per share, a transaction worth $70.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,272
Price
$31.16
Total value
$70.8K
InsiderTousignant Jennifer
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 31, 2025
Filing dateJanuary 2, 2026
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Consists of shares purchased under the Issuer's employee stock purchase plan.